Childhood Reactive Thrombocytosis

Reactive Thromobocytosis in Children Clinical Trial

— RT  

Official title:

Childhood Reactive Thrombocytosis (RT)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01230528
• Other study ID #: WFH-PED 002 Version.2/990603
• Status: Completed
• Phase: N/A
• First received: October 27, 2010
• Last updated: October 28, 2010
• Start date: July 2009
• Est. completion date: June 2010

Study information

• Verified date: October 2010
• Source: Taipei Medical University WanFang Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Reactive thrombocytosis (RT) in pediatric patients is common, but usually without symptoms. The incidence of RT is different depending on age. Mostly, we reasoned that RT is a phenomenon, nevertheless the diagnostic value of RT is little known. Therefore, the aim of this study was to determine the association of RT and clinical or laboratory characteristics in pediatric diseases.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: June 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• The platelet counts more than 500x109/l and age less than 18 years old.

Exclusion Criteria:

• repeated hospitalization ( more than 2 times)

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Reactive Thromobocytosis in Children
• Thrombocytopenia
• Thrombocytosis

Locations

Country	Name	City	State
Taiwan	Taipei Medical University-WanFang Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan,